Seroquel (Quetiapine) is FDA-Approved for Psychotic Disorders
Seroquel (quetiapine) is indicated for the treatment of psychotic disorders, specifically schizophrenia and bipolar disorder, but NOT for Parkinson's disease, tardive dyskinesia, hypertension, or type 2 diabetes 1.
FDA-Approved Indications
According to the FDA drug label, quetiapine is approved for:
- Schizophrenia - Management of psychotic manifestations including positive symptoms (hallucinations, delusions) and negative symptoms (emotional withdrawal, apathy) 1, 2
- Bipolar disorder - Treatment of acute manic episodes and bipolar depression 1
The drug works through antagonism of multiple neurotransmitter receptors, with higher affinity for serotonin (5-HT2A) receptors relative to dopamine (D2) receptors 2.
NOT Indicated For
Parkinson's Disease
While quetiapine has been used off-label to treat drug-induced psychosis in Parkinson's disease patients, this is not an FDA-approved indication 3, 4. The evidence is mixed - some open-label studies suggest benefit 4, but systematic reviews of randomized controlled trials show quetiapine failed to significantly reduce psychotic symptoms compared to placebo when objectively measured 5. Current expert consensus considers quetiapine only "possibly useful" for Parkinson's disease psychosis, with pimavanserin and clozapine having stronger evidence 6, 7.
Tardive Dyskinesia
Quetiapine is not a treatment for tardive dyskinesia. In fact, as an antipsychotic, quetiapine itself carries risk of causing tardive dyskinesia - a potentially irreversible movement disorder 1. The atypical antipsychotics have lower risk than typical antipsychotics, but the risk still exists 8. One case report describes using quetiapine to manage a patient WITH tardive dyskinesia (not to treat it), but this was for managing the underlying schizophrenia while avoiding worsening of the movement disorder 9.
Hypertension
Quetiapine has no role in treating hypertension. Conversely, it can cause orthostatic hypotension as an adverse effect through α1-adrenergic antagonist properties 1. The drug label specifically warns about hypotension risk and recommends caution in patients with cardiovascular disease 1.
Type 2 Diabetes
Quetiapine is not indicated for diabetes treatment. Instead, atypical antipsychotics including quetiapine are associated with metabolic side effects including weight gain, hyperglycemia, and increased diabetes risk 10. Guidelines recommend annual screening for diabetes in patients prescribed atypical antipsychotics, and careful monitoring of weight and glycemic control if these medications must be used 10.
Clinical Context
The confusion may arise because quetiapine appears in guidelines for various conditions, but always as treatment for psychotic symptoms occurring in those conditions, not as treatment for the underlying disease itself. For example:
- In Alzheimer's disease guidelines, quetiapine is listed for controlling "problematic delusions, hallucinations, severe psychomotor agitation, and combativeness" - not for treating dementia 8
- In Parkinson's disease, it may be considered for drug-induced psychosis, but only as off-label use with limited evidence 3, 6
The core indication remains treatment of primary psychotic disorders: schizophrenia and bipolar disorder 1.